Entropy Neurodynamics Webinar: Advancing Psychedelic Science for Disorders in Neuropsychiatry

Entropy Neurodynamics presents TRP-8803, an intravenous psilocybin infusion therapy designed to address limitations in current oral psychedelic treatments for conditions such as refractory IBS, fibromyalgia, and binge eating disorder. Traditional treatments face challenges like slow onset, lack of dosing control, and extended treatment duration. TRP-8803 aims to improve clinical outcomes through precision, controlled administration, and real-time EEG monitoring to predict treatment efficacy. By enabling precise adjustments to the depth and duration of the psychedelic state, this therapy enhances patient safety and provides potential for scalable, medicalized psychedelic interventions.